McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
- Fujitsu Technology to Solve Combinatorial Optimization Problems for Medium-Sized Drug Discovery on September 18, 2018 at 12:07 pm
Fujitsu Laboratories Ltd. today announced that it has developed a large-scale problem segmentation technology, produced together with Fujitsu Advanced Technologies Limited, that utilizes the Digital A... […]
- Manchester drug discovery company bids to raise £11m from new shares on September 18, 2018 at 6:42 am
Manchester pharmaceutical specialist C4X Discovery today (September 18) announced plans to raise up to £10m through the placing of new shares with existing and new institutional investors. And in orde... […]
- Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange on September 18, 2018 at 5:41 am
U.S. pharmaceutical company Verseon has become the latest medical organization to experiment in blockchain technology, it confirmed in a press release Tuesday, September 18. Verseon’s main ... […]
- Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership Team on September 17, 2018 at 5:29 pm
CAMBRIDGE, England--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has made two senior ... […]
- UNIST-Ulsan develop organs-on-chips for new drug discovery on September 17, 2018 at 6:41 am
UNIST and Ulsan will initiate a research collaboration to develop human organs-on-chips in hoping to reduce the time and cost for new drug discovery. The UNIST-WRIRM-UniBasel Organ Mimetic Research Ce... […]
- Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Melvin R. Goodes Prize on September 17, 2018 at 6:08 am
NEW YORK, Sept. 17, 2018 /PRNewswire/ -- Dr. Michela Gallagher has been named the recipient of the 2018 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the A... […]
- Aclaris Therapeutics to Highlight Drug Discovery Targeting the Human Kinome at 16th Annual Discovery on Target Meeting on September 17, 2018 at 4:13 am
The abstracts will be available in the conference program book. One poster describes Aclaris’ proprietary KINect™ platform for human protein kinase cysteinome drug discovery. Many human ... […]
- Vertex’s David Altshuler Humanizes Drug Discovery on September 13, 2018 at 12:35 pm
Dr. David Altshuler speaking at the Advances in Genome Biology and Technology meeting. [AGBT] To kick off the Advances in Genome Biology and Technology (AGBT) precision health meeting held in La Jolla ... […]
- Scientists Harness AI, Deep Learning To Fast-Track Drug Discovery And Development on September 13, 2018 at 11:37 am
The cost of developing a new pharmaceutical drug, from the research and development stage to market approval, runs at about $2.6 billion, according to a 2014 report published by the Tufts Center for t... […]
- OU natural product drug discovery lab helps students gain research experience, encourages new undergraduates to get involved on September 11, 2018 at 8:14 am
An OU natural product drug discovery lab is working with undergraduate student researchers to discover new natural compounds and apply them toward the medical field. Robert H. Cichewicz, regents’ prof... […]
via Google News and Bing News